Senate Bill 97
116th Congress(2019-2020)
Affordable and Safe Prescription Drug Importation Act
Introduced
Introduced in Senate on Jan 10, 2019
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
97
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Bernie Sanders
grade
Vermont
California
Connecticut
Maine
Maryland
Massachusetts
Michigan
Minnesota
Minnesota
New Hampshire
New Hampshire
New Jersey
New Mexico
New Mexico
New York
Ohio
Oregon
Oregon
Pennsylvania
Rhode Island
Rhode Island
Vermont
Washington
West Virginia
Wisconsin
No Senate votes have been held for this bill.
Summary
Affordable and Safe Prescription Drug Importation Act
This bill addresses the importation of drugs from Canada and other foreign countries.
The bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain prescription drugs from Canada. After two years, The FDA, may permit the importation of prescription drugs from other countries.
The bill establishes a process for certifying foreign sellers—a licensed foreign pharmacy or foreign wholesale distributor.
January 10, 2019
Sort by most recent
01/10/2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
01/10/2019
Introduced in Senate
Public Record
Record Updated
Nov 1, 2022 1:49:18 PM